Vitalant Opened Analytics Lab in Phoenix

The new facility at the Phoenix Bioscience Core will support advanced research for cell and gene therapy developers.

Updated on Oct. 8, 2026 in Biotech

Bold flat-color editorial illustration in navy, cream, and red depicting a geometric centrifuge and flask, representing biotechnology infrastructure. — Vitalant has opened a new analytics laboratory at the Phoenix Bioscience Core to support advanced cell and gene therapy research. AI Illustration. Upload story photo >

Vitalant has launched an analytics laboratory within the 30-acre Phoenix Bioscience Core. The facility provides specialized characterization of allogeneic donors and immune profiling for scientific partners.

Why it matters

The lab supports therapy developers by providing access to scientific expertise and donor datasets. It serves as a key resource for those seeking to accelerate complex cell and gene therapy research.

The laboratory offers assay development support across multiple cell-based analytics platforms. It operates within a 30-acre innovation district located in downtown Phoenix.

The players

Vitalant

Vitalant is a nonprofit organization that serves as one of the largest blood services providers in the United States.

Phoenix Bioscience Core

The Phoenix Bioscience Core is a 30-acre life sciences innovation district situated in the heart of downtown Phoenix.

The details

The site offers characterization of allogeneic donors and immune profiling to help researchers streamline their work. Vitalant is also exploring data-driven methods to improve therapy selection based on specific patient-cell characteristics.

Vitalant expanded its coagulation laboratory in Pittsburgh during the summer of 2026.
The new analytics laboratory in Phoenix was launched in October 2026.

The Tech Race

The lab's arrival deepens the concentration of specialized medical analytics within the Phoenix Bioscience Core. This move mirrors a wider industry trend toward collocating high-end biological research with major clinical innovation hubs.

By providing advanced donor characterization, the lab helps speed up the development of new cell-based treatments. For patients, this translates into a potentially faster path to accessing innovative, personalized therapies.

The takeaway

This expansion represents a growing focus on the intersection of data analytics and biological research. Researchers are increasingly utilizing large datasets to tailor therapies to individual patient needs.